We studied patients with dystonia (D) and essential tremor (ET) using positron emission tomography (PET) equipped with Cortex ID software. This allowed PET brain visualisation to be compared to scans of a control group by means of the z-score. The study revealed hypo-metabolism in both D and ET groups, and additionally revealed a difference between these two groups of patients in certain areas of the brain. These two nosological forms overlap in clinical features and are difficult to differentiate. The PET picture may help to provide a differential diagnosis in addition to the biochemical difference in dopamine exchange previously revealed by us in this group of patients.
Introduction
Patients with essential tremor (ET) usually suffer from shaking hands, but the tremor may also affect the head, voice and other parts of the body. In contrast to rest tremor, which is typically present in patients with Parkinson's disease and has a relatively slow frequency (3) (4) (5) , ET is typically more frequent (4) (5) (6) (7) (8) (9) (10) and is most evident during activity such as writing, holding objects or reaching out when eating. Some patients with ET also can suffer from other movement disorders such as dystonia (D). Dystonia is a neurological disorder manifested by repetitive or sustained (squeezing) contractions of the muscles causing abnormal movements or postures. About 25% of patients with cervical dystonia have tremor in their hands and arms similar to ET. This observation has sparked a debate about the relationship between dystonia and ET. Some clinicians have proposed that the hand/arm tremor in patients with cervical dystonia is another form of dystonia, while others argue that ET and dystonia are two separate disorders that may co-exist in the same individual or the same family. Until we discover a validated biological or physiological diagnostic marker for the two disorders, the controversy will probably continue. Hitherto published studies, in which positron emission tomography (PET) was employed, showed very promising results, testifying a potential utility of PET for differential diagnosis of patients with extrapyramidal pathologies. [1] [2] [3] [4] In an attempt to contribute to the ongoing efforts to find such a differential tool, we undertook a study to compare the results of brain PET with 2-18 F-2-deoxi-D-glucose ( 18 F-FDG) of patients with dystonia with the results of patients with essential tremor, analysing the data with the help of the calculation method of the z-score of PET results.
Materials and methods
Patients were recruited by searching the archives of case stories of inpatients treated in the period 1970-2009 in the neurological department at the former medical academy of post-educational study, St. Petersburg, and in the archives of the Neurological Department of the First Pavlov State Medical University of St. Petersburg, Russia. We telephoned patients with D and ET diagnoses to suggest a PET examination. PET was also offered to those D and ET outpatients who applied to our clinic for neurological consultation.
Patients with D and ET suffer from two main clinical symptoms: tremor and hyperkinesis. Tremor prevails in ET, whereas hyperkinesis prevails in D. The group of 14 patients with hyperkinesis and tremor were divided into two groups: group D, which consisted of 10 patients who had hyperkinesis in the form of involuntary movements and postures unrelated to the presence/ absence of tremor, and group ET, which consisted of four patients who had tremor but did not have hyperkinesis. Ten adult patients, mainly with focal or segmental D (two males and 8 females; M age ¼ 47 years), comprised the group of 10 dystonic patients, three of whom also suffered from tremor. Four patients with tremor (two males and two females; M age ¼ 50 years) comprised the ET group, all of whom had head tremor and one whose tremor extended to the hands. The detailed characteristics of the patients studied are presented in Table 1 . Patients were studied at the Russian Scientific Center of Radiology and Surgical Technologies, St. Petersburg, Russia. The study was approved by the institute's ethical committee. Glucose brain metabolism was studied using an Exact high-resolution PET scanner (Siemens, Erlangen, Germany) with 18 F-FDG. PET imaging works by the detection of radiation inside the body. The radiation generated by the decay of radiotracers contains an unstable radionuclide. In the decay process, a positron (b þ ) and neutrino are simultaneously emitted. The positron hits an electron (b -), resulting in an annihilation reaction, which results in energy being produced. This energy forms two 'annihilation' photons (511 keV), from the point of b þ -b À interaction in opposite directions. The annihilated photons are measured using the principles of coincidence PET detection of gamma rays. The photons are then converted into electrical signals that are registered by the tomography electronics. The information is processed to form a complex three-dimensional real-time image of the area being studied, for example the brain. In the 1990s, it was demonstrated that the glucose analogue We analysed the data from patients by means of the z-score by comparing their data to that from a control group of 53 age-matched healthy volunteers (29 women and 24 men; M age ¼ 44 years) who were invited for the brain PET solely for the purpose of calculating the z-scores.
Preliminary PET data were converted from ECAT7 format into the DICOM format and were then downloaded onto the Advantage Workstation 4.5 and 4.6. To do this, we used Vinci 3 software (Max-PlanckInstitute of Neurological Research, Cologne, Germany). The data obtained were analysed using STATISTICA for Windows v10. We used non-parametric c2 tests with Yates's correction and Fisher's criterion for the frequency comparison. We also used Wald's criterion, the Mann-Whitney criterion, median chi-square criterion and the Kruskal-Wallis criterion. Most attention was paid to the Wald-Wolfowitz criterion of adjacent 'runs', which better corresponds to our number of observations and challenges the hypothesis that two independent samples are drawn from two populations that differ significantly.
Results
The study revealed the hypo-metabolism of glucose in all patients with D and ET. Figure 1 shows the brain A significant difference was observed in four areas: the left thalamus (metabolism in D is lower; p < 0.01), the right nucleus lenticularis (metabolism in D is lower; p < 0.01), the girus cingularis (metabolism in ET is lower; p < 0.01) and the pons (metabolism in ET is lower; p < 0.05).
PET with 18 F-FDG of one of our patients, with hypometabolism revealed in certain areas of the brain: the nucleus caudatus, thalamus, nucleus lentiformis, frontal, temporal and parietal cortex. These are indicated in Table 2 . The mean values of the z-score from Table 2 are introduced in Table 3 .
In order to reveal possible pathologic pattern of set of affected and interconnected brain zones inherent to D and/or ET, we built the correlation matrix of glucose hypo-metabolism zones, which is presented in Table 4 .
Another finding of our research is that there was a significant difference in glucose metabolism between group D and group ET, which was detected in four areas of the brain: the left thalamus, the right nucleus lenticularis, the girus cingularis and the pons (Figures 2-5) .
It is intriguing that these four areas of the brain that differ significantly between these two disorders by absolute z-score values also appear to differ significantly from one another by how frequently they are affected ( Figure 6 ). The same two areas of the thalamus and the nucleus lenticularis that exhibit decreased metabolism in group D compared to group ET are also affected more frequently in group D. Likewise, the areas of the pons and the girus cingularis that exhibit a more prominent decrease in metabolism in the ET group compared to the D group are also more frequently affected in ET.
We have revealed a negative correlation between plasma dopamine level and the z-score of brain glucose metabolism (i.e. a negative correlation between dopamine level and glucose hypometabolism) in the temporal cortex, which is presented in Figure 7 .
Discussion
The results of this study were calculated by means of the z-score method that was proposed by Minoshima in 1995. 5 This is based on a method developed earlier at the Michigan Technology University of image standardisation of stereotactic surface projection (3D SSP), where z is for coordinates in the system of the stereotactic brain atlas of Talairach. 6 In the present study, we revealed a decrease in glucose brain metabolism in all studied patients with D and ET. The affected areas were the nucleus caudatus, thalamus, nucleus lentiformis, and the temporal, frontal, prefrontal and parietal cortex, the latter three appearing to be interconnected in one pathologic pattern. Reports of PET with 18 F-FDG in D are contradictory. Some research has reported glucose hyper-metabolism, 7-9 while others have not found any changes in glucose brain metabolism. [10] [11] [12] [13] Our own investigations 1 confirm the report of Karbe 14 of glucose hypo-metabolism in different brain areas in D, but they contradict many of the other above-mentioned studies. The discrepancy may be due to the fact that our patients were untreated. The results of investigations of PET in ET are less controversial, [15] [16] [17] [18] probably due to the fewness of such studies. Korean scientists 19 have confirmed our data of decreased glucose brain metabolism, although more prominent lesions were found in the cortex. Another of our findings is a significant difference between D and ET in terms of the extent of the decrease of glucose brain metabolism in four areas: the left thalamus, right nucleus lenticularis, girus cingularis and the pons. This discovery is particularly important, given that clinical features of extrapyramidal pathologies such as Parkinson disease, D and ET overlap and a differential diagnosis can be embarrassing. In search for solution scientists extensively explore this area, and emissive neuro -visualisation methods have the potential to resolve the problem. For example, it was proven recently that single-photon emission computed tomography and PET can differentiate Parkinson's disease from ET based on different regional blood flow, 2 different serotonin transporter binding 20 and loss of dopaminergic neurons. 21, 22 PET has been proven to be effective in the differentiation of Parkinson's disease from parkinsonian syndromes using PET with 18 F-FDG 3,4,23 and PET with F-dopa. [24] [25] [26] Applying the above-mentioned radio-pharmacological agents to compare D and ET could expand the limits of the present study. The scientific base for the utility of PET in differential diagnoses of extrapyramidal disorders is the correspondence of biochemical polymorphism to PET polymorphism. According to our findings, dopamine exchange disturbance is more inherent in ET than it is in D. Most ET patients were found to have increased plasma dopamine level, whereas increased plasma dopamine in D patients was revealed only in those patients with inherited writer's cramp. The observed negative correlation of temporal glucose hypometabolism and plasma dopamine level when rising dopamine is accompanied by an increment of glucose metabolism toward the norm is confusing. The reason for this is unknown, and we can only speculate that ET increases the dopamine but spares the temporal cortex, and/or D keeps the level of dopamine normal but affects the temporal cortex with decreasing glucose metabolism.
Conclusion
We conclude that brain PET with 18 F-FDG is effective in the differential diagnosis of movement disorders.
Further development of the method lies in the search for and use of new radio-pharmacologic agents. Our study from 2010 1 included the same group of patients but without z-scores, by means of the SPM2 software environment MATLAB v. 6.1.This failed to detect any difference between the D group and the ET group. The z-score further helped us to unveil more brain areas with decreased metabolism. These two facts prove that the z-score is a much more powerful diagnostic tool compared to simple calculations.
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